CMG Chipotle Mexican Grill | $3,186.97 +2.4% | 4/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $3,250.00 -> $3,350.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
HCP HashiCorp | $32.59 -0.7% | 4/24/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 4/24/2024 |
LFMD LifeMD | $11.95 +10.4% | 4/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $13.00 -> $14.00 | Low | View details for BTIG Research rating of LifeMD (NASDAQ:LFMD) on 4/23/2024 |
WGS GeneDx | $11.08 -0.8% | 4/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $15.00 | Low | View details for BTIG Research rating of GeneDx (NASDAQ:WGS) on 4/22/2024 |
PINE Alpine Income Property Trust | $14.93 -0.1% | 4/22/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $23.00 -> $19.00 | Low | View details for BTIG Research rating of Alpine Income Property Trust (NYSE:PINE) on 4/22/2024 |
ISRG Intuitive Surgical | $375.33 +0.6% | 4/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $412.00 -> $421.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 4/19/2024 |
|
DMTK DermTech | $0.60 +3.4% | 4/19/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of DermTech (NASDAQ:DMTK) on 4/19/2024 |
FVRR Fiverr International | $20.80 +3.7% | 4/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $30.00 -> $28.00 | Low | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 4/18/2024 |
EFC Ellington Financial | $11.71 +0.9% | 4/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.50 -> $13.50 | Low | View details for BTIG Research rating of Ellington Financial (NYSE:EFC) on 4/18/2024 |
FIP FTAI Infrastructure | $7.31 -1.3% | 4/18/2024 | Initiated by | BTIG Research | - | Buy | $10.00 | Low | View details for BTIG Research rating of FTAI Infrastructure (NASDAQ:FIP) on 4/18/2024 |
CGEM Cullinan Oncology | $25.30 +31.4% | 4/17/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $30.00 | N/A | View details for BTIG Research rating of Cullinan Oncology (NASDAQ:CGEM) on 4/17/2024 |
BXMT Blackstone Mortgage Trust | $17.91 +1.5% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $22.00 | N/A | View details for BTIG Research rating of Blackstone Mortgage Trust (NYSE:BXMT) on 4/17/2024 |
FBRT Franklin BSP Realty Trust | $12.74 +1.3% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.00 -> $14.00 | N/A | View details for BTIG Research rating of Franklin BSP Realty Trust (NYSE:FBRT) on 4/17/2024 |
RC Ready Capital | $8.85 +1.7% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $12.00 -> $10.00 | N/A | View details for BTIG Research rating of Ready Capital (NYSE:RC) on 4/17/2024 |
STWD Starwood Property Trust | $19.50 +2.0% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $23.00 | N/A | View details for BTIG Research rating of Starwood Property Trust (NYSE:STWD) on 4/17/2024 |
XNCR Xencor | $19.98 +3.9% | 4/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $56.00 -> $38.00 | Low | View details for BTIG Research rating of Xencor (NASDAQ:XNCR) on 4/16/2024 |
DHI D.R. Horton | $145.33 +0.8% | 4/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $174.00 -> $169.00 | Low | View details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 4/16/2024 |
HAFN Hafnia | $7.66 +1.5% | 4/12/2024 | Initiated by | BTIG Research | - | Buy | $10.00 | Low | View details for BTIG Research rating of Hafnia (NYSE:HAFN) on 4/12/2024 |
TBPH Theravance Biopharma | $9.12 -0.2% | 4/12/2024 | Initiated by | BTIG Research | - | Buy | $21.00 | Low | View details for BTIG Research rating of Theravance Biopharma (NASDAQ:TBPH) on 4/12/2024 |
CARM Carisma Therapeutics | $1.64
| 4/11/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Carisma Therapeutics (NASDAQ:CARM) on 4/11/2024 |
RCEL AVITA Medical | $8.52 +2.7% | 4/11/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of AVITA Medical (NASDAQ:RCEL) on 4/11/2024 |
DCGO DocGo | $3.61 +3.4% | 4/10/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $13.00 -> $11.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 4/10/2024 |
APP AppLovin | $73.82 +6.7% | 4/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $87.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 4/9/2024 |
OM Outset Medical | $2.40 +0.8% | 4/8/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Outset Medical (NASDAQ:OM) on 4/8/2024 |
MSTR MicroStrategy | $1,282.38 +3.4% | 4/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $780.00 -> $1,800.00 | Low | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 4/5/2024 |
ADPT Adaptive Biotechnologies | $2.60 -0.4% | 4/4/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 4/4/2024 |
RVLV Revolve Group | $19.81 +2.0% | 4/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $22.00 -> $24.00 | Low | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 4/3/2024 |
KEX Kirby | $112.00 -0.1% | 4/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $115.00 | Low | View details for BTIG Research rating of Kirby (NYSE:KEX) on 4/3/2024 |
SHCR Sharecare | $0.81 +9.5% | 4/1/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Sharecare (NASDAQ:SHCR) on 4/1/2024 |
PIII P3 Health Partners | $0.45 -6.3% | 4/1/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of P3 Health Partners (NASDAQ:PIII) on 4/1/2024 |
CMG Chipotle Mexican Grill | $3,186.97 +2.4% | 3/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $2,750.00 -> $3,250.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 3/28/2024 |
CYBR CyberArk Software | $242.60 -1.0% | 3/28/2024 | Initiated by | BTIG Research | - | Buy | $317.00 | Low | View details for BTIG Research rating of CyberArk Software (NASDAQ:CYBR) on 3/28/2024 |
OTLK Outlook Therapeutics | $8.43 +2.9% | 3/27/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $50.00 | Low | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 3/27/2024 |
VKTX Viking Therapeutics | $74.31 +7.9% | 3/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $125.00 | Low | View details for BTIG Research rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
NUVB Nuvation Bio | $2.68 +2.3% | 3/26/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $5.00 | Low | View details for BTIG Research rating of Nuvation Bio (NYSE:NUVB) on 3/26/2024 |
MASI Masimo | $136.14 +0.7% | 3/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $145.00 -> $166.00 | Low | View details for BTIG Research rating of Masimo (NASDAQ:MASI) on 3/25/2024 |
PZZA Papa John's International | $63.10 +0.3% | 3/22/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Papa John’s International (NASDAQ:PZZA) on 3/22/2024 |
SFL SFL | $13.24 +0.8% | 3/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $13.00 -> $15.00 | Low | View details for BTIG Research rating of SFL (NYSE:SFL) on 3/20/2024 |
HQY HealthEquity | $80.26 +1.5% | 3/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $110.00 | Low | View details for BTIG Research rating of HealthEquity (NASDAQ:HQY) on 3/20/2024 |
JANX Janux Therapeutics | $47.39 +0.6% | 3/21/2024 | Initiated by | BTIG Research | - | Buy | $62.00 | Low | View details for BTIG Research rating of Janux Therapeutics (NASDAQ:JANX) on 3/21/2024 |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
USFD US Foods | $51.35 +1.8% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $52.00 -> $62.00 | Low | View details for BTIG Research rating of US Foods (NYSE:USFD) on 3/19/2024 |
CLSK CleanSpark | $19.23 -1.6% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $12.00 -> $22.00 | Low | View details for BTIG Research rating of CleanSpark (NASDAQ:CLSK) on 3/19/2024 |
TDW Tidewater | $95.72 +2.7% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $90.00 -> $110.00 | Low | View details for BTIG Research rating of Tidewater (NYSE:TDW) on 3/19/2024 |
MXCT MaxCyte | $3.71 +0.5% | 3/13/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for BTIG Research rating of MaxCyte (NASDAQ:MXCT) on 3/13/2024 |
SHAK Shake Shack | $104.88 +3.5% | 3/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $120.00 | Low | View details for BTIG Research rating of Shake Shack (NYSE:SHAK) on 3/14/2024 |
LFMD LifeMD | $11.95 +10.4% | 3/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $13.00 | N/A | View details for BTIG Research rating of LifeMD (NASDAQ:LFMD) on 3/15/2024 |
VKTX Viking Therapeutics | $74.31 +7.9% | 3/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $86.00 -> $100.00 | Low | View details for BTIG Research rating of Viking Therapeutics (NASDAQ:VKTX) on 3/15/2024 |
GMED Globus Medical | $50.55 +0.4% | 3/18/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $60.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 3/18/2024 |
HLTH Cue Health | $0.14
| 3/14/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Cue Health (NASDAQ:HLTH) on 3/14/2024 |
BTDR Bitdeer Technologies Group | $6.35 -1.7% | 3/13/2024 | Initiated by | BTIG Research | - | Buy | $15.00 | Low | View details for BTIG Research rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 3/13/2024 |
TKNO Alpha Teknova | $1.73 +1.8% | 3/12/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Alpha Teknova (NASDAQ:TKNO) on 3/12/2024 |
IDYA IDEAYA Biosciences | $39.94 +3.4% | 3/8/2024 | Initiated by | BTIG Research | - | Buy | $55.00 | Low | View details for BTIG Research rating of IDEAYA Biosciences (NASDAQ:IDYA) on 3/8/2024 |
GNL Global Net Lease | $6.91 -0.1% | 3/8/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Global Net Lease (NYSE:GNL) on 3/8/2024 |
ZLDPF Zealand Pharma A/S | $86.77 +0.7% | 3/7/2024 | Initiated by | BTIG Research | - | Buy | | Low | View details for BTIG Research rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 3/7/2024 |
SOPH SOPHiA GENETICS | $5.03 +1.6% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $7.00 -> $8.00 | Low | View details for BTIG Research rating of SOPHiA GENETICS (NASDAQ:SOPH) on 3/6/2024 |
CRWD CrowdStrike | $304.07 +2.0% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $322.00 -> $432.00 | N/A | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
HCP HashiCorp | $32.59 -0.7% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $25.00 -> $27.00 | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
MGNX MacroGenics | $14.56 +1.3% | 3/4/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $12.00 -> $24.00 | Low | View details for BTIG Research rating of MacroGenics (NASDAQ:MGNX) on 3/4/2024 |
COMP Compass | $3.30 +2.5% | 2/29/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $4.50 -> $4.30 | Low | View details for BTIG Research rating of Compass (NYSE:COMP) on 2/29/2024 |
MRSN Mersana Therapeutics | $2.94 +3.2% | 2/29/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $6.00 | Low | View details for BTIG Research rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024 |
BMBL Bumble | $10.49 -0.6% | 2/28/2024 | Target Lowered by | BTIG Research | - | Buy | $20.00 -> $15.00 | Low | View details for BTIG Research rating of Bumble (NASDAQ:BMBL) on 2/28/2024 |
ANAB AnaptysBio | $21.00 +11.3% | 2/26/2024 | Initiated by | BTIG Research | - | Buy | $55.00 | Low | View details for BTIG Research rating of AnaptysBio (NASDAQ:ANAB) on 2/26/2024 |
TTD Trade Desk | $84.73 +1.7% | 2/23/2024 | Target Raised by | BTIG Research | - | Buy | $91.00 -> $98.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 2/23/2024 |
PLL Piedmont Lithium | $12.17 +6.6% | 2/23/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Piedmont Lithium (NASDAQ:PLL) on 2/23/2024 |
ETSY Etsy | $67.43 +0.3% | 2/22/2024 | Target Lowered by | BTIG Research | - | Buy | $90.00 -> $87.00 | Low | View details for BTIG Research rating of Etsy (NASDAQ:ETSY) on 2/22/2024 |
UBER Uber Technologies | $69.05 -0.4% | 2/22/2024 | Target Raised by | BTIG Research | - | Buy | $80.00 -> $90.00 | Low | View details for BTIG Research rating of Uber Technologies (NYSE:UBER) on 2/22/2024 |
FLYX flyExclusive | $4.30 +4.6% | 2/22/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of flyExclusive (NYSE:FLYX) on 2/22/2024 |
GHLD Guild | $13.63 +1.0% | 2/21/2024 | Initiated by | BTIG Research | - | Buy | $18.00 | Low | View details for BTIG Research rating of Guild (NYSE:GHLD) on 2/21/2024 |
CBAY CymaBay Therapeutics | $32.48
| 2/13/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of CymaBay Therapeutics (NASDAQ:CBAY) on 2/13/2024 |
IQV IQVIA | $234.88 +0.4% | 2/13/2024 | Initiated by | BTIG Research | - | Buy | $285.00 | Low | View details for BTIG Research rating of IQVIA (NYSE:IQV) on 2/13/2024 |
PYXS Pyxis Oncology | $4.30
| 2/9/2024 | Initiated by | BTIG Research | - | Buy | $8.00 | Low | View details for BTIG Research rating of Pyxis Oncology (NASDAQ:PYXS) on 2/9/2024 |
CMG Chipotle Mexican Grill | $3,186.97 +2.4% | 2/7/2024 | Target Raised by | BTIG Research | - | Buy | $2,650.00 -> $2,750.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 2/7/2024 |
PCTY Paylocity | $157.06 +0.3% | 2/6/2024 | Initiated by | BTIG Research | - | Buy | $200.00 | Low | View details for BTIG Research rating of Paylocity (NASDAQ:PCTY) on 2/6/2024 |
PYCR Paycor HCM | $17.86 +1.4% | 2/6/2024 | Initiated by | BTIG Research | - | Buy | $26.00 | Low | View details for BTIG Research rating of Paycor HCM (NASDAQ:PYCR) on 2/6/2024 |
PAYC Paycom Software | $188.89 +1.2% | 2/6/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Paycom Software (NYSE:PAYC) on 2/6/2024 |
MCD McDonald's | $273.09 -0.9% | 2/6/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of McDonald’s (NYSE:MCD) on 2/6/2024 |
BOOT Boot Barn | $107.79 +0.5% | 2/1/2024 | Target Lowered by | BTIG Research | - | Buy | $102.00 -> $100.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 2/1/2024 |
SBUX Starbucks | $88.25 +0.5% | 1/31/2024 | Target Lowered by | BTIG Research | - | Buy | $125.00 -> $115.00 | Low | View details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 1/31/2024 |
SQ Block | $74.48 +2.3% | 1/30/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $85.00 | Low | View details for BTIG Research rating of Block (NYSE:SQ) on 1/30/2024 |
PNST Pinstripes | $3.06 -3.2% | 1/29/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Pinstripes (NYSE:PNST) on 1/29/2024 |
CCSI Consensus Cloud Solutions | $12.27 -1.6% | 1/26/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 1/26/2024 |
BE Bloom Energy | $10.60 +11.0% | 1/25/2024 | Initiated by | BTIG Research | - | Buy | $21.00 | Low | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 1/25/2024 |
MDAI Spectral AI | $1.85 +0.5% | 1/23/2024 | Initiated by | BTIG Research | - | Buy | $4.00 | Low | View details for BTIG Research rating of Spectral AI (NASDAQ:MDAI) on 1/23/2024 |
FLYX flyExclusive | $4.30 +4.6% | 1/23/2024 | Initiated by | BTIG Research | - | Buy | $9.00 | Low | View details for BTIG Research rating of flyExclusive (NYSE:FLYX) on 1/23/2024 |
S SentinelOne | $21.56 +1.7% | 1/22/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $30.00 | Low | View details for BTIG Research rating of SentinelOne (NYSE:S) on 1/22/2024 |
MTTR Matterport | $4.72 +0.9% | 1/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Matterport (NASDAQ:MTTR) on 1/19/2024 |
SMRT SmartRent | $2.36 +1.7% | 1/19/2024 | Initiated by | BTIG Research | - | Buy | $4.50 | Low | View details for BTIG Research rating of SmartRent (NYSE:SMRT) on 1/19/2024 |
CSGP CoStar Group | $92.65 +2.6% | 1/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of CoStar Group (NASDAQ:CSGP) on 1/19/2024 |
APPF AppFolio | $242.75 +12.0% | 1/19/2024 | Initiated by | BTIG Research | - | Buy | $215.00 | Low | View details for BTIG Research rating of AppFolio (NASDAQ:APPF) on 1/19/2024 |
PSFE Paysafe | $14.46 -0.3% | 1/17/2024 | Initiated by | BTIG Research | - | Buy | $19.00 | Low | View details for BTIG Research rating of Paysafe (NYSE:PSFE) on 1/17/2024 |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
MARA Marathon Digital | $19.43 +2.2% | 1/17/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $27.00 | Low | View details for BTIG Research rating of Marathon Digital (NASDAQ:MARA) on 1/17/2024 |
ACRS Aclaris Therapeutics | $1.20 +0.8% | 1/11/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Aclaris Therapeutics (NASDAQ:ACRS) on 1/11/2024 |
BIIB Biogen | $208.90 +3.2% | 1/7/2024 | Reiterated by | BTIG Research | Analyst T. Shrader | Neutral | | Low | View details for BTIG Research rating of Biogen (NASDAQ:BIIB) on 1/7/2024 |
PYPL PayPal | $65.96 +2.9% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of PayPal (NASDAQ:PYPL) on 1/5/2024 |
GOGL Golden Ocean Group | $14.05 +1.7% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Golden Ocean Group (NASDAQ:GOGL) on 1/5/2024 |
GNK Genco Shipping & Trading | $21.55 +1.5% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Genco Shipping & Trading (NYSE:GNK) on 1/5/2024 |
EGLE Eagle Bulk Shipping | $62.60
| 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Eagle Bulk Shipping (NASDAQ:EGLE) on 1/5/2024 |
CMG Chipotle Mexican Grill | $3,186.97 +2.4% | 1/4/2024 | Target Raised by | BTIG Research | - | Buy | $2,175.00 -> $2,650.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 1/4/2024 |
NTRA Natera | $91.66 +0.4% | 12/29/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $85.00 | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 12/29/2023 |
NEO NeoGenomics | $14.14 +2.1% | 12/29/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $25.00 -> $21.00 | Low | View details for BTIG Research rating of NeoGenomics (NASDAQ:NEO) on 12/29/2023 |
HPP Hudson Pacific Properties | $5.72 +0.7% | 12/29/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $13.00 | Low | View details for BTIG Research rating of Hudson Pacific Properties (NYSE:HPP) on 12/29/2023 |
BSX Boston Scientific | $73.17 -0.1% | 12/29/2023 | Reiterated by | BTIG Research | - | Buy -> Buy | $64.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 12/29/2023 |
LSPD Lightspeed Commerce | $13.40 +1.4% | 12/28/2023 | Target Raised by | BTIG Research | - | Buy | $20.00 -> $24.00 | Low | View details for BTIG Research rating of Lightspeed Commerce (NYSE:LSPD) on 12/28/2023 |
ORGO Organogenesis | $2.35 +2.6% | 12/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $4.00 -> $6.00 | Low | View details for BTIG Research rating of Organogenesis (NASDAQ:ORGO) on 12/27/2023 |
EXPE Expedia Group | $135.70 -0.4% | 12/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $175.00 | Low | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 12/27/2023 |
OVID Ovid Therapeutics | $3.10 +3.7% | 12/21/2023 | Initiated by | BTIG Research | - | Buy | $11.00 | Low | View details for BTIG Research rating of Ovid Therapeutics (NASDAQ:OVID) on 12/21/2023 |
SYRE Spyre Therapeutics | $33.56 +3.4% | 12/20/2023 | Initiated by | BTIG Research | - | Buy | $32.00 | Low | View details for BTIG Research rating of Spyre Therapeutics (NASDAQ:SYRE) on 12/20/2023 |
APGE Apogee Therapeutics | $47.13 +2.8% | 12/20/2023 | Initiated by | BTIG Research | - | Buy | $43.00 | Low | View details for BTIG Research rating of Apogee Therapeutics (NASDAQ:APGE) on 12/20/2023 |
OPEN Opendoor Technologies | $2.14 +3.4% | 12/20/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | N/A | View details for BTIG Research rating of Opendoor Technologies (NASDAQ:OPEN) on 12/20/2023 |
EXEL Exelixis | $23.70 +0.7% | 12/19/2023 | Initiated by | BTIG Research | - | Buy | $27.00 | Low | View details for BTIG Research rating of Exelixis (NASDAQ:EXEL) on 12/19/2023 |
TRIP Tripadvisor | $27.45 +4.6% | 12/14/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $25.00 | Low | View details for BTIG Research rating of Tripadvisor (NASDAQ:TRIP) on 12/14/2023 |
VEL Velocity Financial | $17.01 +0.8% | 12/12/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $14.00 -> $17.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 12/12/2023 |
CLSK CleanSpark | $19.23 -1.6% | 12/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $10.00 -> $12.00 | Low | View details for BTIG Research rating of CleanSpark (NASDAQ:CLSK) on 12/11/2023 |
MSTR MicroStrategy | $1,282.38 +3.4% | 12/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $560.00 -> $690.00 | Low | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 12/11/2023 |
HCP HashiCorp | $32.59 -0.7% | 12/8/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $33.00 -> $25.00 | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 12/8/2023 |
AURA Aura Biosciences | $7.22 +2.0% | 12/8/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $38.00 -> $21.00 | Low | View details for BTIG Research rating of Aura Biosciences (NASDAQ:AURA) on 12/8/2023 |
DECK Deckers Outdoor | $833.46 +3.3% | 12/7/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $650.00 -> $800.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 12/7/2023 |
BRZE Braze | $41.71 +1.3% | 12/7/2023 | Target Raised by | BTIG Research | - | Buy | $60.00 -> $75.00 | Low | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 12/7/2023 |
CXM Sprinklr | $11.93 +0.8% | 12/7/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Sprinklr (NYSE:CXM) on 12/7/2023 |
AVDX AvidXchange | $11.96 +1.1% | 12/6/2023 | Initiated by | BTIG Research | - | Buy | $14.00 | Low | View details for BTIG Research rating of AvidXchange (NASDAQ:AVDX) on 12/6/2023 |
XTNT Xtant Medical | $0.95 +5.6% | 12/5/2023 | Initiated by | BTIG Research | - | Buy | $2.00 | N/A | View details for BTIG Research rating of Xtant Medical (NYSEAMERICAN:XTNT) on 12/5/2023 |
RWT Redwood Trust | $5.72 +0.9% | 12/5/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $8.50 | Low | View details for BTIG Research rating of Redwood Trust (NYSE:RWT) on 12/5/2023 |
STC Stewart Information Services | $62.45 +1.3% | 12/4/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $70.00 | Low | View details for BTIG Research rating of Stewart Information Services (NYSE:STC) on 12/4/2023 |
AKBA Akebia Therapeutics | $1.34 +0.8% | 11/29/2023 | Reiterated by | BTIG Research | - | Buy | $4.00 | Low | View details for BTIG Research rating of Akebia Therapeutics (NASDAQ:AKBA) on 11/29/2023 |
CRWD CrowdStrike | $304.07 +2.0% | 11/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $192.00 -> $239.00 | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 11/27/2023 |
ZS Zscaler | $177.05 +1.3% | 11/22/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $191.00 -> $229.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 11/22/2023 |
NTST NETSTREIT | $17.00 -0.1% | 11/22/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $23.00 -> $19.00 | Low | View details for BTIG Research rating of NETSTREIT (NYSE:NTST) on 11/22/2023 |
VSTM Verastem | $9.38 +1.8% | 11/21/2023 | Reiterated by | BTIG Research | - | Buy | $27.00 | Low | View details for BTIG Research rating of Verastem (NASDAQ:VSTM) on 11/21/2023 |
OXM Oxford Industries | $106.71 +0.9% | 11/21/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Oxford Industries (NYSE:OXM) on 11/21/2023 |
FL Foot Locker | $21.98 +0.2% | 11/21/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Foot Locker (NYSE:FL) on 11/21/2023 |
GPN Global Payments | $124.57 0.0% | 11/20/2023 | Initiated by | BTIG Research | - | Buy | $135.00 | Low | View details for BTIG Research rating of Global Payments (NYSE:GPN) on 11/20/2023 |
WKHS Workhorse Group | $0.16
| 11/15/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Workhorse Group (NASDAQ:WKHS) on 11/15/2023 |
GP GreenPower Motor | $1.83 -0.5% | 11/15/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of GreenPower Motor (NASDAQ:GP) on 11/15/2023 |
NOTE FiscalNote | $1.37 +7.9% | 11/15/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of FiscalNote (NYSE:NOTE) on 11/15/2023 |
RBOT Vicarious Surgical | $0.27 +3.8% | 11/14/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Vicarious Surgical (NYSE:RBOT) on 11/14/2023 |
GTLB GitLab | $55.46 -1.0% | 11/13/2023 | Initiated by | BTIG Research | - | Buy | $56.00 | Low | View details for BTIG Research rating of GitLab (NASDAQ:GTLB) on 11/13/2023 |
VUZI Vuzix | $1.32 -1.5% | 11/10/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Vuzix (NASDAQ:VUZI) on 11/10/2023 |
MODN Model N | $29.64 +0.1% | 11/10/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Model N (NYSE:MODN) on 11/10/2023 |
FREY FREYR Battery | $1.67 +5.7% | 11/10/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of FREYR Battery (NYSE:FREY) on 11/10/2023 |
LVLU Lulu's Fashion Lounge | $1.22 +8.0% | 11/9/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Lulu’s Fashion Lounge (NASDAQ:LVLU) on 11/9/2023 |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
DNA Ginkgo Bioworks | $0.86 +10.3% | 11/9/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Ginkgo Bioworks (NYSE:DNA) on 11/9/2023 |
OMCL Omnicell | $27.86 +2.7% | 11/3/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Omnicell (NASDAQ:OMCL) on 11/3/2023 |
DECK Deckers Outdoor | $833.46 +3.3% | 10/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $640.00 -> $650.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 10/27/2023 |
SHYF The Shyft Group | $11.26 +0.3% | 10/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of The Shyft Group (NASDAQ:SHYF) on 10/27/2023 |
HR Healthcare Realty Trust | $14.14 +0.8% | 10/24/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $17.00 | Low | View details for BTIG Research rating of Healthcare Realty Trust (NYSE:HR) on 10/24/2023 |
SKLZ Skillz | $6.10 -2.1% | 10/23/2023 | Upgraded by | BTIG Research | - | Sell -> Neutral | | Low | View details for BTIG Research rating of Skillz (NYSE:SKLZ) on 10/23/2023 |
VEL Velocity Financial | $17.01 +0.8% | 10/23/2023 | Initiated by | BTIG Research | - | Buy | $14.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 10/23/2023 |
IVR Invesco Mortgage Capital | $8.56 +1.5% | 10/20/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Invesco Mortgage Capital (NYSE:IVR) on 10/20/2023 |
GMAB Genmab A/S | $28.15 +2.5% | 10/13/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $44.00 -> $46.00 | Low | View details for BTIG Research rating of Genmab A/S (NASDAQ:GMAB) on 10/13/2023 |
MTNB Matinas BioPharma | $0.18
| 10/11/2023 | Reiterated by | BTIG Research | - | Buy -> Buy | $3.00 | N/A | View details for BTIG Research rating of Matinas BioPharma (NYSEAMERICAN:MTNB) on 10/11/2023 |
WRBY Warby Parker | $12.92 +1.3% | 10/12/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $17.00 | Low | View details for BTIG Research rating of Warby Parker (NYSE:WRBY) on 10/12/2023 |
LYRA Lyra Therapeutics | $4.72 -8.7% | 10/6/2023 | Reiterated by | BTIG Research | - | Buy | $15.00 | Low | View details for BTIG Research rating of Lyra Therapeutics (NASDAQ:LYRA) on 10/6/2023 |
ETSY Etsy | $67.43 +0.3% | 10/6/2023 | Target Lowered by | BTIG Research | - | | $108.00 -> $90.00 | Low | View details for BTIG Research rating of Etsy (NASDAQ:ETSY) on 10/6/2023 |
UWMC UWM | $6.39
| 10/5/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $6.00 | Low | View details for BTIG Research rating of UWM (NYSE:UWMC) on 10/5/2023 |
KIDS OrthoPediatrics | $30.26 +1.1% | 10/3/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $59.00 -> $52.00 | Low | View details for BTIG Research rating of OrthoPediatrics (NASDAQ:KIDS) on 10/3/2023 |
PMN ProMIS Neurosciences | $1.98 +1.5% | 10/2/2023 | Initiated by | BTIG Research | - | Buy | $8.00 | Low | View details for BTIG Research rating of ProMIS Neurosciences (NASDAQ:PMN) on 10/2/2023 |
MCD McDonald's | $273.09 -0.9% | 10/2/2023 | Target Lowered by | BTIG Research | - | | $315.00 -> $300.00 | Low | View details for BTIG Research rating of McDonald’s (NYSE:MCD) on 10/2/2023 |
RBLX Roblox | $36.01 +1.4% | 10/2/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $54.00 -> $52.00 | Low | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 10/2/2023 |
LGIH LGI Homes | $95.85 +1.0% | 10/2/2023 | Upgraded by | BTIG Research | - | Sell -> Neutral | | Low | View details for BTIG Research rating of LGI Homes (NASDAQ:LGIH) on 10/2/2023 |
INSW International Seaways | $55.13 +1.0% | 9/28/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $45.00 -> $55.00 | Low | View details for BTIG Research rating of International Seaways (NYSE:INSW) on 9/28/2023 |
FLYW Flywire | $20.79 +1.2% | 9/28/2023 | Initiated by | BTIG Research | - | Buy | $37.00 | Low | View details for BTIG Research rating of Flywire (NASDAQ:FLYW) on 9/28/2023 |
TRUE TrueCar | $2.88 +2.9% | 9/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of TrueCar (NASDAQ:TRUE) on 9/27/2023 |
SPLK Splunk | $156.90
| 9/26/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Splunk (NASDAQ:SPLK) on 9/26/2023 |
LYFT Lyft | $16.37 +1.9% | 9/26/2023 | Reiterated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Lyft (NASDAQ:LYFT) on 9/26/2023 |
APP AppLovin | $73.82 +6.7% | 9/26/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $40.00 -> $46.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 9/26/2023 |
HPP Hudson Pacific Properties | $5.72 +0.7% | 9/26/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $11.00 | Low | View details for BTIG Research rating of Hudson Pacific Properties (NYSE:HPP) on 9/26/2023 |
CSR Centerspace | $64.59 +0.4% | 9/25/2023 | Reiterated by | BTIG Research | - | Buy | $69.00 | Low | View details for BTIG Research rating of Centerspace (NYSE:CSR) on 9/25/2023 |
MORF Morphic | $28.07 +0.3% | 9/25/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Morphic (NASDAQ:MORF) on 9/25/2023 |
CART Maplebear | $34.69 +0.4% | 9/22/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Maplebear (NASDAQ:CART) on 9/22/2023 |
BSX Boston Scientific | $73.17 -0.1% | 9/21/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $62.00 -> $64.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 9/21/2023 |
TDW Tidewater | $95.72 +2.7% | 9/20/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $91.00 | Low | View details for BTIG Research rating of Tidewater (NYSE:TDW) on 9/20/2023 |
HLX Helix Energy Solutions Group | $11.32 +0.3% | 9/20/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $14.00 -> $17.00 | Low | View details for BTIG Research rating of Helix Energy Solutions Group (NYSE:HLX) on 9/20/2023 |
FTI TechnipFMC | $26.59
| 9/20/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $23.00 -> $28.00 | Low | View details for BTIG Research rating of TechnipFMC (NYSE:FTI) on 9/20/2023 |
DCGO DocGo | $3.61 +3.4% | 9/19/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.00 -> $13.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 9/19/2023 |
SHOO Steven Madden | $40.48 +1.9% | 9/19/2023 | Reiterated by | BTIG Research | - | Buy | $40.00 | Low | View details for BTIG Research rating of Steven Madden (NASDAQ:SHOO) on 9/19/2023 |
LEN Lennar | $154.29 +1.0% | 9/18/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $148.00 -> $161.00 | Low | View details for BTIG Research rating of Lennar (NYSE:LEN) on 9/18/2023 |
GNL Global Net Lease | $6.91 -0.1% | 9/18/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $19.00 -> $15.00 | Low | View details for BTIG Research rating of Global Net Lease (NYSE:GNL) on 9/18/2023 |
CIFR Cipher Mining | $4.50 +1.6% | 9/15/2023 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Cipher Mining (NASDAQ:CIFR) on 9/15/2023 |
PANW Palo Alto Networks | $291.42 +0.9% | 9/13/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $270.00 -> $292.00 | Low | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 9/13/2023 |
OFIX Orthofix Medical | $12.99 -0.8% | 9/12/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Orthofix Medical (NASDAQ:OFIX) on 9/12/2023 |
BRZE Braze | $41.71 +1.3% | 9/8/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $50.00 -> $54.00 | Low | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 9/8/2023 |
CBAY CymaBay Therapeutics | $32.48
| 9/8/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $22.00 -> $24.00 | Low | View details for BTIG Research rating of CymaBay Therapeutics (NASDAQ:CBAY) on 9/8/2023 |
ZS Zscaler | $177.05 +1.3% | 9/6/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $185.00 -> $191.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 9/6/2023 |
PIII P3 Health Partners | $0.45 -6.3% | 8/31/2023 | Initiated by | BTIG Research | - | Buy | $5.00 | Low | View details for BTIG Research rating of P3 Health Partners (NASDAQ:PIII) on 8/31/2023 |
CRWD CrowdStrike | $304.07 +2.0% | 8/31/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $188.00 -> $192.00 | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 8/31/2023 |
BRZE Braze | $41.71 +1.3% | 8/31/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $43.00 -> $50.00 | Low | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 8/31/2023 |
OTLK Outlook Therapeutics | $8.43 +2.9% | 8/30/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | N/A | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/30/2023 |
TMCI Treace Medical Concepts | $10.40 +1.0% | 8/28/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $32.00 -> $27.50 | Low | View details for BTIG Research rating of Treace Medical Concepts (NASDAQ:TMCI) on 8/28/2023 |
ZBH Zimmer Biomet | $119.35 -0.3% | 8/28/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $139.00 | Low | View details for BTIG Research rating of Zimmer Biomet (NYSE:ZBH) on 8/28/2023 |
UPWK Upwork | $11.56 +3.4% | 8/28/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 8/28/2023 |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
SPLK Splunk | $156.90
| 8/24/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $128.00 -> $137.00 | Low | View details for BTIG Research rating of Splunk (NASDAQ:SPLK) on 8/24/2023 |
GMAB Genmab A/S | $28.15 +2.5% | 8/24/2023 | Initiated by | BTIG Research | - | Buy | | Low | View details for BTIG Research rating of Genmab A/S (NASDAQ:GMAB) on 8/24/2023 |
RCUS Arcus Biosciences | $15.55 +5.6% | 8/23/2023 | Reiterated by | BTIG Research | - | Buy -> Buy | $70.00 | Low | View details for BTIG Research rating of Arcus Biosciences (NYSE:RCUS) on 8/23/2023 |
PANW Palo Alto Networks | $291.42 +0.9% | 8/21/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $259.00 -> $270.00 | Low | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 8/21/2023 |
DCGO DocGo | $3.61 +3.4% | 8/18/2023 | Initiated by | BTIG Research | - | Buy | $15.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 8/18/2023 |
FL Foot Locker | $21.98 +0.2% | 8/17/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $42.00 -> $35.00 | Low | View details for BTIG Research rating of Foot Locker (NYSE:FL) on 8/17/2023 |
JKHY Jack Henry & Associates | $164.88 -0.6% | 8/17/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $200.00 -> $173.00 | Low | View details for BTIG Research rating of Jack Henry & Associates (NASDAQ:JKHY) on 8/17/2023 |
BFI BurgerFi International | $0.38
| 8/17/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $5.00 -> $4.00 | Low | View details for BTIG Research rating of BurgerFi International (NASDAQ:BFI) on 8/17/2023 |
INVH Invitation Homes | $34.72 +0.7% | 8/17/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Invitation Homes (NYSE:INVH) on 8/17/2023 |
TLIS Talis Biomedical | $9.14 +1.6% | 8/16/2023 | Target Raised by | BTIG Research | - | Sell -> Sell | $5.00 | Low | View details for BTIG Research rating of Talis Biomedical (NASDAQ:TLIS) on 8/16/2023 |
MQ Marqeta | $5.41 +0.9% | 8/16/2023 | Downgraded by | BTIG Research | - | Neutral -> Sell | $4.00 | Low | View details for BTIG Research rating of Marqeta (NASDAQ:MQ) on 8/16/2023 |
DCTH Delcath Systems | $5.30 +0.8% | 8/15/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $19.00 -> $20.00 | Low | View details for BTIG Research rating of Delcath Systems (NASDAQ:DCTH) on 8/15/2023 |
MYPS PLAYSTUDIOS | $2.24 +1.4% | 8/14/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of PLAYSTUDIOS (NASDAQ:MYPS) on 8/14/2023 |
IMCR Immunocore | $58.46 +0.8% | 8/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $85.00 -> $91.00 | Low | View details for BTIG Research rating of Immunocore (NASDAQ:IMCR) on 8/11/2023 |
CBAY CymaBay Therapeutics | $32.48
| 8/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $22.00 | Low | View details for BTIG Research rating of CymaBay Therapeutics (NASDAQ:CBAY) on 8/11/2023 |
APP AppLovin | $73.82 +6.7% | 8/10/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $34.00 -> $40.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 8/10/2023 |
BNGO Bionano Genomics | $0.79 +4.0% | 8/10/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $10.00 | Low | View details for BTIG Research rating of Bionano Genomics (NASDAQ:BNGO) on 8/10/2023 |
ACET Adicet Bio | $1.68 -7.2% | 8/10/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $20.00 -> $10.00 | Low | View details for BTIG Research rating of Adicet Bio (NASDAQ:ACET) on 8/10/2023 |
ORGO Organogenesis | $2.35 +2.6% | 8/10/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $10.00 -> $4.00 | Low | View details for BTIG Research rating of Organogenesis (NASDAQ:ORGO) on 8/10/2023 |
CYRX Cryoport | $16.38 +2.2% | 8/10/2023 | Target Lowered by | BTIG Research | - | | $33.00 -> $28.00 | N/A | View details for BTIG Research rating of Cryoport (NASDAQ:CYRX) on 8/10/2023 |
FNF Fidelity National Financial | $50.39 +1.0% | 8/9/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $47.00 -> $48.00 | Low | View details for BTIG Research rating of Fidelity National Financial (NYSE:FNF) on 8/9/2023 |
UPST Upstart | $23.46 +2.8% | 8/9/2023 | Target Lowered by | BTIG Research | - | | $72.00 -> $64.00 | Low | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 8/9/2023 |
BL BlackLine | $60.83 +3.3% | 8/9/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $80.00 -> $70.00 | Low | View details for BTIG Research rating of BlackLine (NASDAQ:BL) on 8/9/2023 |
PANW Palo Alto Networks | $291.42 +0.9% | 8/9/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $307.00 -> $259.00 | Low | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 8/9/2023 |
WE WeWork | $0.13 +8.3% | 8/9/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of WeWork (NYSE:WE) on 8/9/2023 |
AKYA Akoya Biosciences | $3.80 -0.5% | 8/8/2023 | Target Lowered by | BTIG Research | - | | $14.00 -> $11.00 | Low | View details for BTIG Research rating of Akoya Biosciences (NASDAQ:AKYA) on 8/8/2023 |
VCEL Vericel | $46.05 +1.3% | 8/8/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $39.00 | Low | View details for BTIG Research rating of Vericel (NASDAQ:VCEL) on 8/8/2023 |
DMTK DermTech | $0.60 +3.4% | 8/7/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for BTIG Research rating of DermTech (NASDAQ:DMTK) on 8/7/2023 |
SPT Sprout Social | $51.39 +0.1% | 8/6/2023 | Target Lowered by | BTIG Research | - | | $76.00 -> $70.00 | Low | View details for BTIG Research rating of Sprout Social (NASDAQ:SPT) on 8/6/2023 |
ESNT Essent Group | $53.98 +0.2% | 8/4/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $50.00 -> $55.00 | Low | View details for BTIG Research rating of Essent Group (NYSE:ESNT) on 8/4/2023 |
DKNG DraftKings | $43.13 +5.0% | 8/4/2023 | Target Raised by | BTIG Research | - | | $34.00 -> $39.00 | Low | View details for BTIG Research rating of DraftKings (NASDAQ:DKNG) on 8/4/2023 |
PZZA Papa John's International | $63.10 +0.3% | 8/4/2023 | Target Lowered by | BTIG Research | - | | $100.00 -> $95.00 | Low | View details for BTIG Research rating of Papa John’s International (NASDAQ:PZZA) on 8/4/2023 |
FVRR Fiverr International | $20.80 +3.7% | 8/3/2023 | Target Raised by | BTIG Research | - | Buy | $40.00 -> $44.00 | Low | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 8/3/2023 |
QTWO Q2 | $53.28 +0.7% | 8/3/2023 | Target Raised by | BTIG Research | - | | $36.00 -> $42.00 | Low | View details for BTIG Research rating of Q2 (NYSE:QTWO) on 8/3/2023 |
BOOT Boot Barn | $107.79 +0.5% | 8/3/2023 | Target Raised by | BTIG Research | - | | $98.00 -> $115.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 8/3/2023 |
GKOS Glaukos | $99.48 -0.6% | 8/3/2023 | Target Raised by | BTIG Research | - | | $83.00 -> $86.00 | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 8/3/2023 |
LGIH LGI Homes | $95.85 +1.0% | 8/2/2023 | Target Raised by | BTIG Research | - | | $77.00 -> $103.00 | Low | View details for BTIG Research rating of LGI Homes (NASDAQ:LGIH) on 8/2/2023 |
PEN Penumbra | $204.41 -0.5% | 8/2/2023 | Target Lowered by | BTIG Research | - | | $351.00 -> $308.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 8/2/2023 |
MTCH Match Group | $31.89 +0.6% | 8/2/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $60.00 | Low | View details for BTIG Research rating of Match Group (NASDAQ:MTCH) on 8/2/2023 |
MLNK MeridianLink | $17.50 +0.6% | 8/2/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of MeridianLink (NYSE:MLNK) on 8/2/2023 |
UBER Uber Technologies | $69.05 -0.4% | 8/1/2023 | Target Raised by | BTIG Research | - | Buy | $55.00 -> $60.00 | Low | View details for BTIG Research rating of Uber Technologies (NYSE:UBER) on 8/1/2023 |
DT Dynatrace | $47.10 +1.1% | 8/1/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $57.00 -> $65.00 | Low | View details for BTIG Research rating of Dynatrace (NYSE:DT) on 8/1/2023 |
SOFI SoFi Technologies | $7.87 +3.7% | 7/31/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $14.00 -> $13.00 | Low | View details for BTIG Research rating of SoFi Technologies (NASDAQ:SOFI) on 7/31/2023 |
ONON ON | $32.79 +2.7% | 7/31/2023 | Initiated by | BTIG Research | - | Sell -> Neutral | | Low | View details for BTIG Research rating of ON (NYSE:ONON) on 7/31/2023 |
RIG Transocean | $5.87 +2.3% | 7/28/2023 | Target Raised by | BTIG Research | - | Buy | $10.00 -> $12.00 | Low | View details for BTIG Research rating of Transocean (NYSE:RIG) on 7/28/2023 |
DTIL Precision BioSciences | $9.38 -3.5% | 7/28/2023 | Target Lowered by | BTIG Research | - | Buy | $180.00 -> $60.00 | Low | View details for BTIG Research rating of Precision BioSciences (NASDAQ:DTIL) on 7/28/2023 |
DECK Deckers Outdoor | $833.46 +3.3% | 7/28/2023 | Target Raised by | BTIG Research | - | Buy | $613.00 -> $640.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 7/28/2023 |
TTD Trade Desk | $84.73 +1.7% | 7/28/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $103.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 7/28/2023 |
MRSN Mersana Therapeutics | $2.94 +3.2% | 7/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Mersana Therapeutics (NASDAQ:MRSN) on 7/27/2023 |
TPIC TPI Composites | $2.78 +16.3% | 7/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of TPI Composites (NASDAQ:TPIC) on 7/27/2023 |
EGP EastGroup Properties | $155.92 +0.1% | 7/26/2023 | Target Raised by | BTIG Research | - | | $198.00 -> $218.00 | Low | View details for BTIG Research rating of EastGroup Properties (NYSE:EGP) on 7/26/2023 |
ATRC AtriCure | $23.17 +2.5% | 7/26/2023 | Target Raised by | BTIG Research | - | | $56.00 -> $68.00 | Low | View details for BTIG Research rating of AtriCure (NASDAQ:ATRC) on 7/26/2023 |
PHM PulteGroup | $113.80 +2.2% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $83.00 -> $100.00 | Low | View details for BTIG Research rating of PulteGroup (NYSE:PHM) on 7/25/2023 |
PYPL PayPal | $65.96 +2.9% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $85.00 -> $90.00 | Low | View details for BTIG Research rating of PayPal (NASDAQ:PYPL) on 7/25/2023 |
OPRT Oportun Financial | $3.15 +1.6% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $7.00 -> $7.50 | Low | View details for BTIG Research rating of Oportun Financial (NASDAQ:OPRT) on 7/25/2023 |
JKHY Jack Henry & Associates | $164.88 -0.6% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $183.00 -> $200.00 | Low | View details for BTIG Research rating of Jack Henry & Associates (NASDAQ:JKHY) on 7/25/2023 |
UPST Upstart | $23.46 +2.8% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $42.00 -> $72.00 | Low | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 7/25/2023 |
ZS Zscaler | $177.05 +1.3% | 7/25/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $185.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 7/25/2023 |
PROK ProKidney | $2.12 -21.8% | 7/24/2023 | Initiated by | BTIG Research | - | Buy | $16.00 | Low | View details for BTIG Research rating of ProKidney (NASDAQ:PROK) on 7/24/2023 |
LADR Ladder Capital | $11.00 +1.9% | 7/24/2023 | Target Raised by | BTIG Research | - | Buy | $10.00 -> $12.50 | Low | View details for BTIG Research rating of Ladder Capital (NYSE:LADR) on 7/24/2023 |